Cara Therapeutics Newsroom

Analyst Ratings For Cara Therapeutics

BenzingaJun 13 20:03

Cara Therapeutics Analyst Ratings

BenzingaJun 13 18:08

Canaccord Genuity Downgrades Cara Therapeutics to Hold From Buy, Adjusts Price Target to $1 From $10

MT NewswiresJun 13 17:47

Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS) and Cara Therapeutics (CARA)

TipRanksMay 23 18:45

Cara Therapeutics Analyst Ratings

BenzingaMay 23 18:30

Needham Reiterates Buy on Cara Therapeutics, Maintains $5 Price Target

BenzingaMay 23 18:30

Cara Therapeutics Analyst Ratings

BenzingaMay 16 00:00

HC Wainwright & Co. Reiterates Buy on Cara Therapeutics, Maintains $3.6 Price Target

BenzingaMay 15 23:40

Analysts Offer Insights on Healthcare Companies: AbSci (ABSI), Iterum Therapeutics (ITRM) and Cara Therapeutics (CARA)

TipRanksMay 14 23:25

Needham: Reiterates Cara Therapeutics (CARA.US) rating and adjusted from buy to buy rating, target price of $5.00.

Zhitong FinanceMay 14 23:11

Cara Therapeutics Analyst Ratings

BenzingaMay 14 23:10

Cara Therapeutics: A Buy Rating Ahead of Key Oral Difelikefalin Trial Results

TipRanksMay 14 19:40

Cara Therapeutics (CARA) Gets a Buy From Stifel Nicolaus

TipRanksMay 14 19:15

Buy Rating Affirmed for Cara Therapeutics: Promising Prospects for Oral Difelikefalin in Notalgia Paresthetica Treatment

TipRanksApr 12 18:20

Needham: Reiterates Cara Therapeutics (CARA.US) rating and adjusted from buy to buy rating, target price of $5.00.

Zhitong FinanceApr 10 18:41

Buy Rating Affirmed for Cara Therapeutics Amidst Promising Korsuva Ph 2/3 Program and Market Potential

TipRanksApr 10 18:41

Cara Therapeutics Analyst Ratings

BenzingaApr 10 18:35

Analysts Are Bullish on These Healthcare Stocks: Celcuity (CELC), Cara Therapeutics (CARA)

TipRanksMar 28 18:06

Cara Therapeutics Analyst Ratings

BenzingaMar 28 17:40

Cara Therapeutics Analyst Ratings

BenzingaMar 6 20:02